Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01720537 · ClinicalTrials.gov registry record · Phase 1

A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

A Phase 1 study of Hypercholesterolemia, sponsored by Pfizer.

Completed
Registry status
Phase 1
Development phase
133
Enrollment target
7
Study locations

NCT01720537 is a Phase 1 study of Hypercholesterolemia that has completed, run by Pfizer. The registered enrollment target is 133 participants, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (84% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01720537, a Phase 1 study of Hypercholesterolemia, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 1
Development phase
133 participants
Enrollment target
7
Study locations

Study Summary

This study is to evaluate the safety, tolerability and immunogenicity of single, ascending or multiple fixed subcutaneous and intravenous administrations of PF 05335810 to hypercholesterolemic subjects when added on to a daily statin dose.

Conditions Studied

Hypercholesterolemia

Interventions

  • BIOLOGICAL Placebo
  • BIOLOGICAL PF-05335810 Dose A
  • BIOLOGICAL PF-05335810 Dose B

Study Locations (7)

Florida

  • Pfizer Investigational Site - Miami
  • Pfizer Investigational Site - South Miami

Connecticut

  • Pfizer Investigational Site - New Haven

Kansas

  • Pfizer Investigational Site - Overland Park

Michigan

  • Pfizer Investigational Site - Kalamazoo

Ohio

  • Pfizer Investigational Site - Cincinnati

Texas

  • Pfizer Investigational Site - San Antonio

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2012-07
Est. Completion 2013-10
Phase Phase 1

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01720537

The ClinicalTrials.gov registry entry for NCT01720537 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 815-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (84% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT01720537 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, Connecticut, Kansas.

Frequently Asked Questions

What is clinical trial NCT01720537 about?

NCT01720537 is a clinical study titled "A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects". This study is to evaluate the safety, tolerability and immunogenicity of single, ascending or multiple fixed subcutaneous and intravenous administrations of PF 05335810 to hypercholesterolemic subjects when added on to a daily statin dose.

What is the current status of trial NCT01720537?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 133 participants. The study started on 2012-07. Estimated completion is 2013-10.

What conditions does trial NCT01720537 study?

This clinical trial studies the following conditions: Hypercholesterolemia.

What interventions are being tested in trial NCT01720537?

The interventions under investigation include: Placebo (BIOLOGICAL), PF-05335810 Dose A (BIOLOGICAL), PF-05335810 Dose B (BIOLOGICAL).

Who is sponsoring clinical trial NCT01720537?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01720537 being conducted?

This trial has 7 study locations across Connecticut, Florida, Kansas, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypercholesterolemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypercholesterolemia

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.